In a letter Tuesday to Novo Nordisk's top executives, Sens. Jeanne Shaheen, D-N.H., Raphael Warnock, D-Ga., and Elizabeth Warren, D-Mass., said the company's decision to discontinue Levemir ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir, arguing that it could leave some diabetics without an ...

The firm attributes its lower revenue projections to conservative estimates for Levemir and Victoza, two of Novo Nordisk's products. With an impressive gross profit margin of 84.66% and a P/E ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...

Levemir (insulin detemir) is safe to receive while pregnant or breastfeeding. However, factors such as the form you get or the condition the drug helps treat may determine whether you should ...

Novo Nordisk has announced that it will stop producing its insulin product, Levemir, after the end of 2024. Eli Lilly is also reducing its production volume of its insulin product, Humalog.

This leaflet answers some common questions about Levemir ® FlexPen ®. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.